FDA needs more funding, NEJM says, amid questions about antidiabetes drug
BMJ
.
2007 Aug 18;335(7615):322.
doi: 10.1136/bmj.39304.603762.DB.
Author
Janice Hopkins Tanne
PMID:
17703024
PMCID:
PMC1949465
DOI:
10.1136/bmj.39304.603762.DB
No abstract available
Publication types
News
MeSH terms
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / economics
Financing, Government
Humans
Hypoglycemic Agents / economics*
United States
United States Food and Drug Administration / economics*
Substances
Hypoglycemic Agents